DEPOMED Aktie

3,96 EUR -0,1009%

Zu Ihrem Onlinebroker

kaufen verkaufen

DEPOMED Aktienkurs : 25.05. ( 15 Min. verzögert)
3,96 € Letzter Kurs	-0,10% Veränderung	3,96 € Vortag	3,96 € Eröffnungskurs

mehr Informationen

Hoch/Tief		Volumen		Geldkurs	Briefkurs
3,96 - 3,96 Tag	6,23 - 3,07 52 Wochen	0 Tag	42 Ø 52 Wochen	4,24 0 Stücke	4,48 0 Stücke

DEPOMED Aktienkurs

Wollen Sie wissen, wie es mit dieser Aktie weitergeht?
Wir informieren Sie kostenlos.

Erhalten Sie außerdem Expertenanalysen von:
Gevestor Täglich und John Gossens Daily DAX

25.05.

Depomed To Present At Jefferies 2012 Global Health Care Conference

By Depomed, Inc. MENLO PARK, Calif., May 25, 2012 -- /PRNewswire/ -- Depomed, Inc. (NASDAQ:DEPO) today announced that it will be presenting...
24.05.

Court Report - Part II - May 23, 2012

Depomed, Inc. v. Zydus Pharmaceuticals (USA), Inc. et al. • Defendants: Zydus Pharmaceuticals (USA), Inc.; Cadila Healthcare Ltd. Infringement of US Patent Nos. 6340475 ("Extending the Duration …

18.05.

The Zacks Analyst Blog Highlights: Watson Pharmaceuticals, Shire, Depomed ...

Stocks recently featured in the blog include Watson Pharmaceuticals Inc. (NYSE:WPI), Shire (Nasdaq:SHPGY), Depomed Inc. (Nasdaq:DEPO), Comcast Corporation (Nasdaq:CMCSA) and Microsoft Corporation (Nasdaq:MSFT). Watson Pharmaceuticals Inc. (NYSE:WPI) ...
18.05.

The Zacks Analyst Blog Highlights: Watson Pharmaceuticals, Shire, Depomed ...

Stocks recently featured in the blog include Watson Pharmaceuticals Inc. (WPI - Analyst Report), Shire (SHPGY - Snapshot Report), Depomed Inc. (DEPO - Analyst Report), Comcast Corporation (CMCSA - Analyst Report) and Microsoft Corporation (MSFT ...
14.05.

Depomed reaches milestone under research collaboration with Ironwood

Depomed has reached $1m milestone payment under its research collaboration and license agreement with Ironwood Pharmaceuticals. The milestone follows the development and delivery of a prototype formu…

weitere News, die den DEPOMED Aktienkurs bewegen

Boersennews.de